Top Biotech Companies in Miami, FL (35)
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This...
Click Therapeutics's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.
Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.
Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.
Quotient Sciences is a global contract research, development, and manufacturing organization (CRDMO) supporting pharmaceutical and biotechnology companies. Its integrated services span early drug development, candidate selection, first-in-human clinical studies, formulation, clinical research, and commercial manufacturing. By combining scientific expertise, data-driven solutions, and collaborative program management, the company helps emerging biotechs and large pharma advance therapies efficiently from molecule to patients.
Vitrolife Group is a global provider of medical devices and genetic testing services for reproductive health and assisted reproduction. The company develops, manufactures, and markets fertility products and advanced software, including time-lapse incubators and embryo evaluation systems. Its mission is to help people fulfill the dream of having a healthy baby, supporting fertility clinics and patients worldwide through innovation and...
Vitrolife Group's Top Stability & Growth Strengths
Profitability: Net income and EPS are described as rising sharply, with gross and EBITDA margins expanding materially, indicating stronger bottom-line performance.
Cost & Operational Efficiency: Disciplined cost control, headcount reductions, and strategic pricing are presented as key actions that improved margins and operational performance.
Strong Market Position & Advantage: The company is often characterized as a leading global player in IVF and reproductive health, supported by a broad portfolio and global reach.
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We also operate a national portfolio of acute care and specialty hospitals, other outpatient facilities, a network of leading employed physicians and...
Bio-Tissue is an ophthalmic biologic therapeutics company that develops innovative regenerative healing and hygiene solutions.
Biorasi is a customer-focused, full-service, contract research organization (CRO) that delivers fast and flexible solutions across global clinical trials to maximize speed-to-market for its sponsors. As the leader in neurology, nephrology, dermatology, and the rare and urgent disease market, Biorasi sets new standards for speed, agility, and quality in patient enrollment, decentralized trials, and data transparency. It is Biorasi’s mission to...
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology, and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter...
Beckman Coulter Diagnostics's Top Stability & Growth Strengths
Strong Market Position & Advantage: Beckman Coulter Diagnostics is widely recognized as a leader in core‑lab IVD with broad adoption of its chemistry, immunoassay, and automation platforms, supported by Danaher’s top‑tier diagnostics portfolio. Multiple analyses place Danaher (including Beckman) among the leading global diagnostics groups, underscoring substantial installed base and reach.
Innovation-Driven Growth: Recent FDA clearances (e.g., DxC 500i, NT‑proBNP on DxI 9000), Breakthrough Device designation for an Alzheimer’s blood test, and expansion of the DxI 9000 assay menu (including neurodegenerative markers) demonstrate an active pipeline. Research‑use‑only biomarker assays and ongoing menu additions further support platform adoption and reagent pull‑through.
Resilient & Sustainable Growth: Management highlighted mid‑single‑digit growth through 2025, with multiple consecutive quarters of mid‑single‑digit or better growth outside China and expectations for gradual end‑market improvement into 2026. The IVD and clinical chemistry analyzer markets are expanding, providing supportive demand tailwinds.
At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. The entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs. We are proud...
A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services. With annual sales of $12 billion and more than 44,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and personalized service to advance food safety, maintain clean and safe environments, optimize water and energy use, and improve...
Ecolab's Top Stability & Growth Strengths
Profitability: Record sales, earnings per share, and operating margins in 2024 and 2025 indicate sustained margin improvement. Feedback suggests continued expansion is expected in 2026 supported by pricing discipline, productivity, and higher‑margin services.
Strong Market Position & Advantage: Ecolab is consistently characterized as a global leader across water, hygiene, and infection prevention with broad industry reach and high customer retention. Feedback suggests external accolades and large-scale operations reinforce a durable competitive moat.
Innovation-Driven Growth: Expansion into high-growth areas like hyperscale data centers, microelectronics, and life sciences is supported by acquisitions and digital services. Feedback suggests AI-enabled analytics, performance-based contracts, and a growing backlog are fueling future growth.
MMS is an award-winning, global clinical research organization (CRO) that supports leading pharmaceutical and biotech companies as well as many smaller enterprises across our spectrum of services. Having completed more than 50 submissions for drug approval over the last 5 years, we remain a top choice for sponsors who are looking for innovation and demand high quality from their CRO...
Lincare is a leading supplier of respiratory-therapy products and services for patients in the home. You can learn more about our extensive suite of products and services by visiting our website. Everywhere we operate, Lincare is working to be a partner in patient care by providing high-quality services and supplies, promoting patient education, and building strong relationships with patients, physicians,...
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Smith & Nephew's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show mid-single-digit underlying growth through 2024–2025, with management reiterating guidance for continued growth in 2026. Early 2026 updates indicate broad-based contributions across units despite some subsegment variability.
Profitability: Trading profit and margins improved, supported by execution of the 12‑Point Plan and the transition to the RISE strategy. Management is guiding to further profit growth alongside higher returns.
Healthy Cash Flow: Free cash flow strengthened in 2025 with guidance for robust generation in 2026. Share repurchases completed and newly announced buybacks signal confidence and disciplined capital allocation.
Vivex Biomedical is a biomedical company developing implant technology and stem cell therapies.
Kappa Laboratories is a full service microbiological and chemical testing laboratory.
In a rapidly changing industry, caregivers remain the constant. Every day they demonstrate their passion for helping people despite unprecedented pressure to increase access and quality of care with the same or fewer resources. Hillrom is driven by patient-centered care. Everything we do, and all our products and technologies, are designed to enhance outcomes for patients and caregivers. It starts...
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases.
Entopsis utilizes a proprietary material science screening platform to develop cost-effective and impactful products. Our leading solutions: 1) OpsisDx: universal platform to diagnose cancer and various diseases thru urine www.entopsis.com 2) PCRopsis: series of time & cost saving technologies for the life sciences
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Biscayne Pharmaceuticals discovers and develops novel therapies based on growth hormone-releasing hormone (GHRH) analogs.
Established in 2016, Tri-Source Pharma was formed for capital investment and management oversight of its subsidiary companies. Its goal is to grow and synergize each of its companies’ ability to expand. Tri-Source has a network of over 60,000 veterinary hospitals and over 150,000 human healthcare providers nationwide, which substantiates its positioning for solid, domestic and global expansion into the Americas...
